Skip to content

The Connect Trial: Connecting Hospital Patients to Alcohol Care

The Connect Trial: Connecting Hospital Patients to Alcohol Care - a Randomized Controlled Feasibility Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07482150
Enrollment
60
Registered
2026-03-19
Start date
2026-03-10
Completion date
2031-09-01
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Keywords

alcohol misuse treatment, inhospital alcohol care, pilot study, implementation study

Brief summary

The main objective of this pilot study is to assess feasibility of conducting a definitive RCT with concealed allocation, blinded outcome assessment and a 1:1 parallel group design of A) an invitation to meet an AUD therapist for up to 10 treatment sessions at the hospital in up to 6 months (intervention) compared to B) guidance on how to seek alcohol care in an AUD treatment centre in the community, outside of the hospital (control).

Interventions

OTHERAUD treatment sessions with an outreach alcohol therapist at the hospital

Participants will be offered an AUD treatment session at the hospital the same or next day as they are enrolled in the study with an outreach alcohol therapist from a local AUD treatment facility. The alcohol therapist will be trained in motivational interviewing and cognitive behavioural therapy for AUD. The session will aim to motivate patients to reduce their alcohol consumption and set goals for AUD treatment. The alcohol therapist can recommend a medical therapy to support alcohol reduction or abstinence - this prescription will be undertaken by a hepatologist from the Department of Medicine and may be continued after discharge by patients´ general practitioner or physicians at the AUD treatment facility. Up to 10 sessions of up to 60 minutes of duration at the hospital during 6 months after the baseline visit can be offered and after that, the participant can continue to meet with the same therapist in the community.

OTHERGuidance and leaflet on AUD treatment facilities outside the hospital

Participants randomised as controls will be offered a leaflet informing about different possibilities for alcohol misuse treatments and guidance on how to approach them (may include referral or help with doing an appointment, if possible according to the specific treatment center) in the catchment area of SUH Køge and Roskilde

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

allocation concealment

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Hospitalised or seen in an outpatient clinic at SUH Køge * Full-filling international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use * Informed written consent * Being able to meet the AUD therapist in connection with a hospital visit with a health condition wholly or partly attributable to alcohol

Exclusion criteria

* Ongoing specialized treatment for AUD * Not speaking Danish * Not living in the catchment area of Zealand University hospital * Age \< 18 years * Enrolled in the Zealand alcohol-related liver disease cohort study

Design outcomes

Primary

MeasureTime frameDescription
Recruitment6 months\>50% of eligible individuals invited to the study give written informed consent
Retention6 months\>50% individuals recruited and randomized to the intervention, will attend to the intervention of seing the AUD therapist at least once
Completion6 months\>50% of all randomized study participants complete the follow-up interview and blood sample

Secondary

MeasureTime frameDescription
AUD treatment engagement after 6 and 12 months12 monthsNo predefined goal
Mortality after 6 and 12 months12 monthsNo predefined goal
Change in drinks (containing 12 g ethanol) per last 30 days from baseline till 6 months after inclusion6 months
Proportion with abstinence or light drinking (<10 drinks/week) last 30 days6 monthsyes or no
Change in blood phosphatidyl ethanol level from baseline to 6 months after inclusion6 months
Change in motivation to cut down on alcohol (yes or no), calculated as the difference between baseline and 6 months follow-up6 months
Number of AUD treatment sessions6 months
Proportion initiating medical AUD therapy6 months
Proportion receiving medical AUD treatment at 6- and 12 months follow up12 months
Number of acute hospital admissions or emergency room visits at 6 and 12 months12 months
Number of hospital outpatient visits at 6 and 12 months12 months
3- year follow-up, conducted through health care registries and AUD treatment facilities to look for incidence of alcohol-related morbidity and mortality, visits to general practitioner and hospital contacts3 years

Countries

Denmark

Contacts

CONTACTGro Askgaard, MD, PhD
gras@regionsjaelland.dk60142280
PRINCIPAL_INVESTIGATORGro Askgaard

Sjaellands Universitetshospital Køge, Medicinsk Afdeling

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026